The Current Research on Biosciences and Biotechnology journal aims to be a leading publication for state-of-the-art research in the biosciences, from Health and Medicine to Biotechnology to Advanced Materials.
Editor-in-Chief
Assoc. Prof. Dr. Elfahmi, M.Si., Apt. (School of Pharmacy, Bandung Institute of Technology, Indonesia)
Editorial Board
Prof. Dr. Ibrahim Jantan (Department of Pharmacy, Faculty of Allied Health Sciences, Universiti Kebangsaan Malaysia)
Prof. Dr. Khairurrijal, M.Si. (Faculty of Mathematics and Natural Sciences, Bandung Institute of Technology, Indonesia)
Prof. Dr. Normah Mohd Noor (Institute of Systems Biology (INBIOSIS), Universiti Kebangsaan Malaysia)
Prof. Dr. I Nyoman Pugeg Aryantha, Ph.D. (School of Life Sciences and Technology, Bandung Institute of Technology, Indonesia)
Prof. Dr. Mohammed Shoeb (Department of Chemistry, University of Dhaka, Bangladesh)
Prof. Dr. I. Sahidin, S.Pd., M.Si. (Faculty of Pharmacy, Halu Oleo University, Indonesia)
Prof. Dr. Muhammad Iqbal Choudary (International Center for Chemical and Biological Sciences, University of Karachi, Pakistan)
Prof. Ikuro Abe, Ph.D (Graduate School of Pharmaceutical Sciences, The University of Tokyo, Japan)
Prof. Dr. Maike Petersen (Institute of Pharmaceutical Biology and Biotechnology, Philipps-University Marburg, Germany)
Prof. Dr. Dra. Berna Elya, Apt., M.Si. (Department of Pharmacy, University of Indonesia)
Dr. Ernawati Arifin Giri-Rachman (School of Life Sciences and Technology, Bandung Institute of Technology, Indonesia)
Dr. Dessy Natalia (Faculty of Mathematics and Natural Sciences, Bandung Institute of Technology, Indonesia)
Dr. Fenny Martha Dwivany (School of Life Sciences & Technology, Bandung Institute of Technology, Indonesia)
Dr. Debbie Soefie Retnoningrum, Apt. (School of Pharmacy, Bandung Institute of Technology, Indonesia)
Managing Editor
Dr. Husna Nugrahapraja (School of Life Sciences and Technology, Bandung Institute of Technology, Indonesia)
Dr.rer.nat. Agus Cahyadi (School of Pharmacy, Bandung Institute of Technology, Indonesia)
Hubbi Nashrullah Muhammad, M.Si. (School of Pharmacy, Bandung Institute of Technology, Indonesia)
Web Manager
Sandy Akbar Nusantara (Biosciences and Biotechnology Research Center, Bandung Institute of Technology)
Given drug discovery timelines and irrespective of technological innovations in the pipeline, it seems likely that [biopharmaceutical] approvals over the next few years will continue to be dominated by mAb-based products and by products synthesized using conventional expression systems and administered by means of conventional parenteral delivery.
Latest Events
Workshop Menangkap dan Mengkarakterisasi Makhluk “Bioghaib” Cendawan
Aug 30, 2018Workshop on Medicinal Plant Biotechnology
May 2, 2018[Workshop Bioinformatics] Introduction to Variant Calling Data Analysis Using NGS Data
Mar 29, 2018Molecular Modeling in Drug Design and Discovery Workshop
Feb 28, 2018
